Co-Diagnostics, Inc. Marketable Securities, Unrealized Gain (Loss)
Co-Diagnostics, Inc. (CODX) reported Marketable Securities, Unrealized Gain (Loss) of $134.07 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-03-31
- Co-Diagnostics, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-06-30 was -$196.59K, a 235.90% decline year-over-year.
- Co-Diagnostics, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-03-31 was $330.65K, a 45.95% increase year-over-year.
- Co-Diagnostics, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2024-12-31 was $10.08K.
- Co-Diagnostics, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2024-09-30 was $37.16K, a 16.50% decline year-over-year.
- Co-Diagnostics, Inc. marketable securities, unrealized gain (loss) for fiscal 2024 was $418.44K, a 185.24% increase from fiscal 2023.
- Co-Diagnostics, Inc. marketable securities, unrealized gain (loss) for fiscal 2023 was $146.70K, a 62.31% decline from fiscal 2022.
- Co-Diagnostics, Inc. marketable securities, unrealized gain (loss) for fiscal 2022 was $389.24K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$196.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $134.07K 10-Q · filed 2025-08-14 | $144.15K derived: sum of 3 quarters · filed 2026-03-31 | $181.30K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | $330.65K 10-Q · filed 2025-05-08 | $340.73K derived: sum of 2 quarters · filed 2026-03-31 | $377.89K derived: sum of 3 quarters · filed 2026-03-31 | $522.54K derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | $10.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $47.23K derived: sum of 2 quarters · filed 2026-03-31 | $191.89K derived: sum of 3 quarters · filed 2026-03-31 | $418.44K 10-K · filed 2026-03-31 |
| 2024-09-30 | $37.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $181.81K derived: sum of 2 quarters · filed 2024-11-07 | $408.37K 10-Q · filed 2024-11-07 | -$258.26K derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-06-30 | $144.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $371.21K 10-Q · filed 2024-08-08 | -$295.42K derived: sum of 3 quarters · filed 2025-03-27 | -$250.91K derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-03-31 | $226.56K 10-Q · filed 2024-05-09 | -$440.07K derived: sum of 2 quarters · filed 2025-03-27 | -$395.57K derived: sum of 3 quarters · filed 2025-03-27 | -$253.03K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-12-31 | -$666.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$622.12K derived: sum of 2 quarters · filed 2025-03-27 | -$479.59K derived: sum of 3 quarters · filed 2025-03-27 | $146.70K 10-K · filed 2025-03-27 |
| 2023-09-30 | $44.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $187.04K derived: sum of 2 quarters · filed 2023-11-09 | $813.32K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $142.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $768.82K 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $626.29K 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $389.24K 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |